2025-04-13 19:01:23
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Shilpa Medicare posts consolidated Q3FY22 net profit of Rs. 9.56 crores
Posted On : 2022-02-08 17:16:18( TIMEZONE : IST )
Shilpa Medicare Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 277.7818 crores during the period ended December 31, 2021 as compared to Rs. 296.5533 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 9.5650 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 19.9602 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 1.13 for the period ended December 31, 2021 as compared to Rs. 2.45 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 277.7818 crs | ₹296.5533 crs |  -6.33% |
| Net Profit | ₹9.5650 crs | ₹ 19.9602 crs | -52.08% |
| EPS | ₹1.13 | ₹2.45 | -53.88% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 277.7818 crores during the period ended December 31, 2021 as compared to Rs.199.8550 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.9.5650 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.7.6683 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.1.13 for the period ended December 31, 2021 as compared to Rs.0.94 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 277.7818 crs | ₹199.8550 crs |  38.99% |
| Net Profit | ₹9.5650 crs | ₹7.6683 crs | 24.73% |
| EPS | ₹1.13 | ₹0.94 | 20.21% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.813.6814 crores during the 9 Months period ended December 31, 2021 as compared to Rs.716.3378 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.31.1132 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.139.3578 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.3.77 for the 9 Months period ended December 31, 2021 as compared to Rs.17.09 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹813.6814 crs | ₹716.3378 crs | 13.59% |
| Net Profit | ₹31.1132 crs | ₹139.3578 crs | -77.67% |
| EPS | ₹3.77 | ₹17.09 | -77.94% |
Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 490.75 as compared to the previous close of Rs. 510.10. The total number of shares traded during the day was 12010 in over 1480 trades.
The stock hit an intraday high of Rs. 516.00 and intraday low of 481.45. The net turnover during the day was Rs. 5951831.00.
